ASH HIGHLIGHTS 2023 – LYMPHOMA ROUNDTABLE DISCUSSION: Mosunetuzumab and Polatuzumab Vedotin Demonstrates Preliminary Efficacy in Elderly Unfit/Frail Patients

Best of Oncology Podcast Series - A podcast by OncologyEducation